FLOR-OPAL VARNISH, MODELS UP 4500/ UP 4501/ UP 4502

K051750 · Ultradent Products, Inc. · LBH · Sep 19, 2005 · Dental

Device Facts

Record IDK051750
Device NameFLOR-OPAL VARNISH, MODELS UP 4500/ UP 4501/ UP 4502
ApplicantUltradent Products, Inc.
Product CodeLBH · Dental
Decision DateSep 19, 2005
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3260
Device ClassClass 2
AttributesTherapeutic

Intended Use

Intended for use as a varnish on sensitive teeth, over exposed dentin under temporary restorative and cements where post-operative sensitive and compressive and coments and cements when used in conjunction with dental restoratives and cements. Product is also intended for use to seal dentinal tubules in cavity preparations or on sensitive root surfaces.

Device Story

Flor-Opal Varnish is a dental varnish containing 5% sodium fluoride in a solvent base. It functions as a dentinal tubule obturator to reduce dental hypersensitivity. The device is applied by a dentist to sensitive teeth, exposed dentin, or root surfaces, and can be used under temporary restoratives and cements. By sealing dentinal tubules, the varnish mitigates post-operative sensitivity and improves the functionality of dental restorations. It is a professional-use product intended for clinical dental settings.

Clinical Evidence

No clinical data provided. Substantial equivalence is based on technological characteristics and intended use comparison to predicate devices.

Technological Characteristics

Composition: 5% sodium fluoride in a solvent base. Function: Dentinal tubule obturator. Form factor: Varnish. Administration: Dentist-applied.

Indications for Use

Indicated for patients requiring treatment for dental hypersensitivity, sealing of dentinal tubules in cavity preparations, or protection of exposed root surfaces. For professional use by dentists.

Regulatory Classification

Identification

Cavity varnish is a device that consists of a compound intended to coat a prepared cavity of a tooth before insertion of restorative materials. The device is intended to prevent penetration of restorative materials, such as amalgam, into the dentinal tissue.

Special Controls

*Classification.* Class II (special controls). The device, when it is an external cleaning solution, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo for Ultradent Products, Inc. The logo is composed of two lines of text, with the first line reading "ULTRADENT" in a bold, sans-serif font. The second line reads "PRODUCTS, INC." in a smaller, thinner font. The logo is black and white. KOS1750 ## SEP 1 9 2005 ## SUMMARY OF SAFETY AND EFFECTIVENESS & STATEMENT OF COMPARISON (as per 21 CFR 807.92c) | 1) Submitted by: | Tammy Lavery<br>Ultradent Products, Inc.<br>505 West 10200 South<br>South Jordan, UT 98004<br>USA | |-----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 2) Establishment Registration No: | 1718912 | | 3) Date Prepared: | 06/21/05 | | 4) Product Proprietary Name: | Flor-Opal Varnish | | 5) Device Common Name: | Dental Varnish | | 6) Device Classification Name: | Cavity Varnish (21 CFR 872.3260) | | 7) Device Class: | Class II (76LBH) | | 8) Substantial equivalence: | The Flor-Opal Varnish which is to be manufactured and marketed by Ultradent Products, Inc., 505 West 10200<br>South, South Jordan, Utah 84095, is substantially<br>equivalent to the legally-marketed devices as noted on<br>the attached document. (Refer to section IV of this<br>510(k) Submission for labeling and added detail for each<br>of the predicates identified). | The 510(k) Substantial Equivalence Decision-Making Process (Detailed) from ODE Guidance Memorandum #86-3 was followed as described below: - 1) The Flor-Opal varnish and the products listed have the same intended use, that being as varnish on sensitive teeth, over exposed dentin, under temporary restoratives and cements, and on exposed dentin on roots. - 2) The technological characteristics for this product are the virtually the same as the predicate devices listed. No significant variation has been implemented. - 3) Descriptive information per the table noted below further shows that the materials from the listed predicate devices are substantially equivalent as they are used for the same purpose and have the relatively the same properties, etc. Page 1 of 2 {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the logo for Ultradent Products, Inc. The logo features a stylized "U" on the left, followed by the word "ULTRADENT" in bold, sans-serif font. Below "ULTRADENT" is the text "PRODUCTS, INC." in a smaller font size. The overall design is simple and professional, conveying a sense of reliability and innovation. - 4) As noted above, the Substantial Equivalence Decision-Making Process Chart was used. See below for a comparison table showing similarities and differences from the predicate devices listed supporting substantial equivalence. ### Similarities: | Predicate Devices | Flor-Opal Varnish | |---------------------------------------------------------------------------|---------------------------------------------------------------------------| | 5% sodium fluoride in a solvent base | 5% sodium fluoride in a solvent base | | Dentinal tubule obturator for the reduction in<br>dental hypersensitivity | Dentinal tubule obturator for the reduction in<br>dental hypersensitivity | | Dentist administered | Dentist administered | #### Differences: | Predicate Devices | Flor-Opal Varnish | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1. The Partify of Children Children Children Children Children Children Children Children Children Children Children Children Children Children Children Children Children Chi | " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " | No significant differences noted with any of the predicate devices and the Flor-Opal Varnishidentified, of the No significan unter thes noted with any of the picture and incredients. All have the same concentration of the active ingredient. ## Conclusion: Per the review noted above in accordance with the guidance document, the Flor-Opal Varnish is found to be substantially equivalent to the identified predicate devices. Peter Allen, Jr. Peter Allred Research and Development Chemist Tammy Lavrry Tammy Lavery Regulatory Affairs Senior Manager 6/23/05 Date **Date** 6/23/05 **Date** Date Page 2 of 2 {2}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its wing and tail. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter of the circle. SEP 1 9 2005 Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Tammy Lavery Regulatory Affairs Senior Manager Ultradent Products, Incorporated 505 West 10200 South South Jordan, Utah 84095 Re: K051750 Trade/Device Name: Flor-Opal Varnish Regulation Number: 21 CFR 872.3260 Regulation Name: Cavity Varnish Regulatory Class: II Product Code: LBH Dated: August 15, 2005 Received: August 26, 2005 Dear Ms. Lavery: We have reviewed your Section 510(k) premarket notification of intent to market the devices indication We have reviewed your Section 510(x) premance from and tate the indications for the indications for referenced above and have decemined the are are as a marketed in interstate commerce use stated in the enclosure) to legally marketed predicants, or to devices that use stated in the enclosure) to icgaily manical Device Amendments, or to devices that proof to May 28, 1970, the chacitient date of the Federal Food, Drug, and Cosmetic have been reclassified in accordance with the provisions of the Federal PMAA . You may have been reclassified in accordance with the provises application (PMA). You may, Act (Act) that do not require approval of a prematice approval application Act . The gener Act (Act) that do not require approval or a premaince of the Act . The general controls provisions of the Act include requirements for annual registration, listing of devices, good adultarstien controls provisions of the Networkships against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (see above) most regulations affecting your device can be may be subject to such additions, Title 21, Parts 800 to 898. In addition, FDA may publish found in the Code of Feach in the Federal Register. {3}------------------------------------------------ Page 2 – Ms. Tammy Lavery Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that ITDA 's Issualice of a substance of a subscanaties of the Act of that FDA has made a decemination that your cell by other Federal agencies. You must comply with CEP P . ( 907) any Pederal Statures and regulations administered by to: registration and listing (21 CFR Part 877); all the Act s requirements, including, but not instructive requirements as set forth in the quality labeling (21 CFR Part 801), good manakassang franks and frankle, the electronic product radiation Systems (QB) regarders (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) I his letter will anow you to begin manieting of substantial equivalence of your device to a legally prematication. The PDA Intellig of basification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific davice 101 your 240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). You may obtain other Misoraniumig of reference to promaibilities under the Act from the Division of Small general information on your responsionner Assistance at its toll-free number (800) 638-204 or Manufacturers, International and Ocusanti v://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Carl Chiu S. Lin, PhD Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ K051750 Page_ 1_of_1 # INDICATIONS FOR USE ## 17651450 510(k) Number (if known): Unknown Device Name: Flor-Opal Varnish Indications for use: Intended for use as a varnish on sensitive teeth, over exposed dentin under temporary restorative Intended for use as a varilish of schildtive its a concern and to improve quality and functionality and cements where post-operative sensitive and compressive and coments and cements when used in conjunction with dental restoratives and cements. Product is also intended for use to seal dentinal tubules in cavity preparations or on sensitive root surfaces. # (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) # Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use:_ X (Per 21 CFR 801.109) OR Over-The-Counter Use:_ Susan Rupp (Optional Format 1-2-9 (Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Dev 510(k) Number:
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%